Gastrointestinal Cancer News

Extrahepatic cancer was more common in patients with hepatitis C and was the leading cause of death in patients who achieved sustained virologic response compared with the general population, according to results of a French cohort study.

Talicia, a novel drug for the treatment of Helicobacter pylori, achieved positive top-line results in a phase 3 study, according to a press release from RedHill Biopharma, the manufacturer.

The increasing prevalence of excess body weight, which was responsible for approximately 3.9% of all cancers worldwide in 2012, is driven by multiple economic and environmental factors and should be addressed through policy actions and other interventions, according to a report published in CA: A Cancer Journal for Clinicians.

The FDA granted orphan drug designation to M7824 for the treatment of biliary tract cancer.

Sorafenib combined with conventional transarterial chemoembolization for patients with advanced hepatocellular carcinoma improved time to progression, progression-free survival, and tumor response rate compared with sorafenib alone, according to a recently published study.

The recent upswing in rates of young-onset colorectal cancer has mostly been due to an increase in rectal cancer, particularly among white patients, according to research published in Gastroenterology.

SAN DIEGO — Rivaroxaban prophylaxis significantly reduced thromboembolic events among patients receiving systemic cancer therapy, according to findings of a double-blind, randomized, placebo-controlled study presented at the late-breaking abstract session of ASH Annual Meeting and Exposition.

SAN DIEGO — Patients with cancer-associated venous thromboembolism treated with oral apixaban appeared significantly less likely to experience VTE recurrence than those who received parenteral dalteparin, according to study results presented at ASH Annual Meeting and Exposition.

A genome-wide analysis of more than 100,000 individuals identified 40 new genetic variants that point to an increased risk for colorectal cancer, according to research published in Nature Genetics.

Evidence from a multicenter cohort study revealed that adenoma detection rates were higher in colonoscopies performed following positive results from a fecal immunochemical test compared with direct screening colonoscopies.